Myriad Genetics, Inc. MYGN

NAS: MYGN | ISIN: US62855J1043 17/09/2026

4,140 USD (+7,25%)

(+7,25%) 17/09/2026

Grafiek Myriad Genetics, Inc.

Grafiek Myriad Genetics, Inc.

1 dag1d 7,25%
1 week1w 21,05%
1 maand1m 44,25%
3 maanden3m -8,81%
6 maanden6m -10,78%
1 jaar1j -46,09%
5 jaar5j -87,55%

Myriad Genetics, Inc. in het nieuws

Toon enkel gratis nieuws

10 augustus 2026 · Myriad Genetics (MYGN) Securities Investigation Notice - Levi & Korsinsky · Persbericht

4 augustus 2026 · MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics · Persbericht

4 augustus 2026 · Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN) · Persbericht

23 september 2025 · Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy · Persbericht

Profiel Myriad Genetics, Inc.

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.myriad.com

Hoofdzetel: Salt Lake City, Utah Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe